POAI - Kewajiban jangka dawa marang modal predictive-oncology.com

Simbol lan logo merek Predictive Oncology Inc. (POAI)

The scalable cloud platform of Predictive Oncology (POAI), which monetizes AI data analytics, drives the dynamics of the long-term debt-to-equity chart, where the ratio is maintained at 0.00. Business development relies on the system's recognition by pharma behemoths and the volume of clinical datasets. Meanwhile, the company's environmental profile is improving by reducing physical chemical tests through digital modeling.

Predictive Oncology Inc. (POAI): Utang jangka dawa marang modal saka 04.07.2022 nganti 12.12.2025
Barang utama Predictive Oncology Inc

Investors use this criterion to assess a business's debt sustainability during fundamental screening. The metric measures the proportion of long-term liabilities relative to equity, determining the degree of financial leverage. For Predictive Oncology (POAI) and its AI developments in oncology, such a financing structure may reflect investments in expanding its tumor database. Analyzing the long-term debt-to-equity ratio allows for the differentiation of strategic growth from liquidity shortages.

Analisis pesaing

Rasio utang jangka dawa marang ekuitas Intuitive Surgical, Inc.|Danaher Corp - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Becton Dickinson & Company (BDX)|STE - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal westpharma.com WST|Utang jangka dawa marang modal BAX (Baxter)|MASI - Rasio tanggungan utang jangka dawa marang modal|STVN (Stevanato) - Utang jangka dawa marang modal|Teleflex Corp (TFX) - Rasio utang jangka dawa marang ekuitas|MMSI (Merit Medical Systems) - Utang jangka dawa marang modal|Utang jangka dawa marang modal NVST|Utang jangka dawa marang ekuitas ICU Medical (ICUI)|Utang jangka dawa marang ekuitas Dentsply Sirona Inc XRAY|Rasio utang jangka dawa marang ekuitas LeMaitre|Koefisien utang jangka dawa marang modal AtriCure Medical ATRC|Utang jangka dawa marang modal STAA (STAAR Surgical Company)|NAGE: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ZimVie|ANGO (AngioDynamics Inc) - Rasio utang jangka dawa marang modal|CERS: Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Teknova Inc (TKNO)|Rasio utang jangka dawa marang ekuitas Monogram Technologies|Rasio silihan jangka dawa marang modal STSS (sharpstechnology.com)|Utang jangka dawa marang ekuitas InfuSystem Holdings, Inc.|UTMD - Koefisien utang jangka dawa marang modal|KORU Medical Systems Inc. - Rasio utang jangka dawa marang ekuitas|NYXH: Utang jangka dawa marang modal|MBOT (Microbot Medical Inc.) - Utang jangka dawa marang ekuitas|pro-dex.com (PDEX) - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal ZTEK (Zentek)|Kewajiban jangka dawa marang modal ELUT|Utang jangka dawa marang ekuitas Milestone Scientific Corp MLSS|Rasio utang jangka dawa marang modal NEXGEL Inc NXGL|Rasio utang jangka dawa marang ekuitas Retractable Technologies, Inc. (RVP)|Harvard Bioscience Inc. - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas FEMY (Femasys)|MHUA: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas callanjmb.com (CJMB)|ATRI (Atrion Corporation Inc.) - Kewajiban jangka dawa marang ekuitas|NURO - Utang jangka dawa marang ekuitas